Histogen Inc (HSTO)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven J. Mento
Employees:
20
10655 SORRENTO VALLEY ROAD, SUITE 200, San Diego, CA, 92121
(858) 526-3100
| Date | Ratio |
|---|---|
| 2022-06-03 | 1:20 |
Histogen Inc. focuses on developing hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee. The company also offers Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|